Navigation Links
Surveyed Physicians Indicate that Xtandi is Prescribed to Nearly One Quarter of Metastatic Castrate-Resistant Prostate Cancer Patients Who Have Failed to Respond to Prior Docetaxel Treatment
Date:5/6/2013

ly secures a first-line label extension for use in chemotherapy-naive, asymptomatic or minimally symptomatic mCRPC, surveyed medical oncologists and urologists would prescribe it to nearly half of their eligible patients. Surveyed respondents' estimates of Xtandi's patient share in this patient population exceeds their current estimates of patient share for any other currently prescribed therapy in this setting, including Zytiga, exemplifying surveyed physicians' enthusiasm for this agent and eagerness to use it earlier in the mCRPC treatment algorithm.

"Xtandi is experiencing rapid uptake within its FDA-approved indication for docetaxel-pretreated mCRPC, and its inclusion on National Comprehensive Cancer Network guidelines for use in chemotherapy-naive, asymptomatic mCRPC patients who are not candidates for docetaxel is spurring its use in this earlier disease setting," said Decision Resources Group Senior Director of Oncology Rachel Webster , D.Phil. "While more than half of surveyed physicians report decreased use of Jevtana (Sanofi's cabazitaxel) in their docetaxel pretreated mCRPC patients, more than half of surveyed respondents currently report no change in their use of Zytiga in this setting."

About BioTrends Research Group
BioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please visit www.bio-trends.com. BioTrends is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Gro
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. At Three Months Post Launch, Two-Thirds of Surveyed U.S. Rheumatologists Believe that Initiations of Pfizers Xeljanz in the Rheumatoid Arthritis Treatment Algorithm Will Occur Following at Least Two Biologic Failures
2. New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual Meeting
3. Physicians for Peace Resource Mothers Program Receives Sweatshirt Blanket Donation
4. Physicians for Peace Receives Logo Embroidered Polo Shirt Donation
5. Texas Fertility Center Introduces Oncofertility Education Program for Physicians and Patients
6. Physicians Endoscopy and Colon Cancer Challenge Foundation Partner to Raise Colon Cancer Awareness
7. Physicians for Peace Resource Mothers Program Receives Fleece Blanket Donation
8. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
9. Douglas Harrington, MD Addresses Select Group Of Physicians Regarding Latest Advances In Cardiovascular Risk Assessment
10. Physicians for Peace Receives Logo Embroidered Lab Coat Donation from Crooked Brook
11. Four Texas Fertility Center Physicians Chosen as Super Doctors®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... focused on advanced wound care, announces that AMNIOEXCEL® ... have been added to the Premier, Inc. Regenerative ... opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   VRML), ... announced today that the Company closed its previously ... Management, Jack W. Schuler , Birchview Fund ... $10.5 million, before offering expenses.  The proceeds will ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... for the First Three Months of 2008., COPENHAGEN, May ... three month period ended March 31, 2008.,During this period, Genmab ... million (approx. USD 36 million) for the,first quarter of 2008. ... 80 million (approx. USD 17 million)., An operating loss ...
... SoluLinK, Inc., a leader in,next-generation conjugation products ... of a new product, NanoLink(TM) Streptavidin Magnetic,Microspheres. ... of any commercially available polymer-encapsulated streptavidin,magnetic microsphere. ... throughput robotic applications where high biotin loads,must ...
... 28 The automation of,transaction-based processing is ... the United States. Foresight Corporation of Dublin, ... scale of installations of Transaction,Insight(R) - the ... Transaction automation techniques enable healthcare organizations to,cut ...
Cached Biology Technology:Genmab Announces 2008 First Quarter Results 2Genmab Announces 2008 First Quarter Results 3Genmab Announces 2008 First Quarter Results 4SoluLinK Introduces NanoLink(TM) Streptavidin Magnetic Microspheres 2New Trend Sweeping Nation's Health Plans: Transaction Automation 2
(Date:1/22/2015)... , January 22, 2015 , ... tenth year  The European Patent Office to present a ... Two British nominations to be featured: Christofer Toumazou and ... featuring former finalists and winners of the Award   ...
(Date:12/22/2014)... 2014  NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... the growing mobile commerce market, announces it has retained famous ... the 2015 International CES debut of the Wocket™ biometric smart ... at the NXT-ID booth January 6th and 7 th , ...
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., ... a study that pinpoints fine-scale differences in genetic ancestry of ... Since immigrants first arrived more than four hundred ... served as a meeting place for peoples from different continents. ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... mutations in BRCA1 and BRCA2 genes have a significantly higher ... risk have been seeking genetic testing and counseling based on ... sequencing is labor-intensive, costly, and it only targets a part ... Canadian scientists has developed a new sequencing approach to provide ...
... emerged centuries ago in Europe has now been ... industrialization. Unlike other diarrheal diseases, this one is ... clean water. As developing countries become more industrialized ... flexneri are known to decline, associated with ...
... (DOE) announced Aug. 2 that a team of engineers ... million to design a battery management system for lithium-ion ... This is a particularly challenging project because the electrochemical ... mathematical form. The project is one of 12 ...
Cached Biology News:New method provides fast, accurate, low cost analysis of BRCA gene mutations in breast cancer 2Out of Europe 2Out of Europe 3$3.2 million to develop battery management system for electric-car batteries 2$3.2 million to develop battery management system for electric-car batteries 3$3.2 million to develop battery management system for electric-car batteries 4
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
IC50: 3 ng/ml · Limit of detection: 0.9 ng/ml...
Request Info...
Image Analysis Software. PC Version of NIH Image....
Biology Products: